共 159 条
[1]
Gutierrez OM(2008)Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 584-592
[2]
Mannstadt M(2011)Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality J Am Soc Nephrol 22 956-966
[3]
Isakova T(2010)The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study Ann Intern Med 152 640-648
[4]
Rauh-Hain JA(2011)Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease JAMA 305 2432-2439
[5]
Tamez H(2011)Fibroblast growth factor 23 in patients undergoing peritoneal dialysis Clin J Am Soc Nephrol 6 2688-2695
[6]
Shah A(2015)Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence Nephrol Dial Transplant 30 310-320
[7]
Smith K(2008)The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? J Nephrol 21 146-160
[8]
Lee H(2000)Predictors of loss of residual renal function among new dialysis patients J Am Soc Nephrol 11 556-564
[9]
Thadhani R(2000)The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients Nephrol Dial Transplant 15 396-401
[10]
Juppner H(1998)Calculation of the protein equivalent of total nitrogen appearance from urea appearance: which formulas should be used? Perit Dial Int 18 467-473